top of page



University College London, London, UK

Nick Freemantle is Professor of Clinical Epidemiology & Biostatistics at University College London (UCL) and Director of the UCL Comprehensive Clinical Trials Unit. He leads a programme of research examining healthcare delivery and practice, and methodology.


Nick is involved in many randomized trials across different phases and clinical areas, from first in human to phase 4.  The interventions range from Advanced Treatment Medical Products to ‘talking therapies’.  All of his work aims to estimate treatment effects relevant to the real world. He is also involved in analyses of ‘Big Data’ addressing questions relevant to healthcare delivery and policy, including the estimation of treatment effects and also the performance of health systems. For example, his recent work on ‘Weekend Effects’ in the National Health Service has had substantial policy impact. Nick was the statistician for the landmark CARE-HF trial of cardiac resynchronisation therapy in heart failure. 


Nick has an active teaching role, supervising postgraduate students from all around the world.

Nick has published more than 370 scientific papers in peer-reviewed journals and is a highly cited author.


Professor Freemantle has received funding for research, travel and consulting from Ipsen, Novo Nordisk, Tesaro, Allegan, Takeda and Sanofi.

bottom of page